These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 3910217)

  • 1. Carboplatin: the clinical evaluation strategy.
    Rozencweig M; Canetta R; Carter SK
    Cancer Treat Rev; 1985 Sep; 12 Suppl A():137-44. PubMed ID: 3910217
    [No Abstract]   [Full Text] [Related]  

  • 2. Carboplatin: the clinical spectrum to date.
    Canetta R; Rozencweig M; Carter SK
    Cancer Treat Rev; 1985 Sep; 12 Suppl A():125-36. PubMed ID: 3002623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carboplatin in the first-line chemotherapy of ovarian cancer.
    Alberts DS; Canetta R; Mason-Liddil N
    Semin Oncol; 1990 Feb; 17(1 Suppl 2):54-60. PubMed ID: 2406922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian trials at the Royal Marsden.
    Wiltshaw E
    Cancer Treat Rev; 1985 Sep; 12 Suppl A():67-71. PubMed ID: 3910224
    [No Abstract]   [Full Text] [Related]  

  • 5. Carboplatin in the treatment of ovarian cancer.
    Alberts DS; Mason-Liddil N
    Semin Oncol; 1989 Apr; 16(2 Suppl 5):19-26. PubMed ID: 2655095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carboplatin and ifosfamide in ovarian cancer phase II and III trials. London Gynaecological Oncology Group.
    Wiltshaw E; Perren TJ; Fryatt ID; Blake PR; Harper P; Slevin M
    Cancer Chemother Pharmacol; 1990; 26 Suppl():S48-50. PubMed ID: 2189595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carboplatin: current status and future prospects.
    Canetta R; Bragman K; Smaldone L; Rozencweig M
    Cancer Treat Rev; 1988 Jun; 15 Suppl B():17-32. PubMed ID: 2841021
    [No Abstract]   [Full Text] [Related]  

  • 8. Systematic review of first-line chemotherapy for newly diagnosed postoperative patients with stage II, III, or IV epithelial ovarian cancer.
    Covens A; Carey M; Bryson P; Verma S; Fung Kee Fung M; Johnston M
    Gynecol Oncol; 2002 Apr; 85(1):71-80. PubMed ID: 11925123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whither carboplatin.
    J Clin Oncol; 1987 Jun; 5(6):984-6. PubMed ID: 3295133
    [No Abstract]   [Full Text] [Related]  

  • 10. Carboplatin.
    Med Lett Drugs Ther; 1989 Sep; 31(800):83-4. PubMed ID: 2671623
    [No Abstract]   [Full Text] [Related]  

  • 11. [Phase III study of carboplatin in ovarian cancer].
    Kato T; Nishimura H; Yamabe T; Terashima Y; Kasamatsu T; Hirabayashi K; Nishiya I; Yajima A; Takamizawa H; Tsutsui F
    Gan To Kagaku Ryoho; 1988 Aug; 15(8):2297-304. PubMed ID: 3044276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carboplatin.
    Betcher DL; Burnham N
    J Assoc Pediatr Oncol Nurses; 1988; 5(4):29-30. PubMed ID: 3060593
    [No Abstract]   [Full Text] [Related]  

  • 13. Carboplatin: future directions.
    Carter SK; Canetta R; Rozencweig M
    Cancer Treat Rev; 1985 Sep; 12 Suppl A():145-52. PubMed ID: 3910218
    [No Abstract]   [Full Text] [Related]  

  • 14. Carboplatin, an active drug in advanced head and neck cancer.
    de Andres Basauri L; Lopez Pousa A; Alba E; Sampedro F
    Cancer Treat Rep; 1986 Oct; 70(10):1173-6. PubMed ID: 3530443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CL 287,110 and CL 286,558.
    Cancer Invest; 1989; 7(5):537. PubMed ID: 2620257
    [No Abstract]   [Full Text] [Related]  

  • 16. Phase II study of carboplatin in patients with ovarian carcinoma: a National Cancer Institute of Canada Clinical Trials Group Study.
    Eisenhauer EA; Swenerton KD; Sturgeon JF; Fine S; O'Reilly SE
    Cancer Treat Rep; 1986 Oct; 70(10):1195-8. PubMed ID: 3530446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II studies with carboplatin in non-small cell lung cancer.
    Gatzemeier U; Heckmayr M; Neuhauss R; Hossfeld D; Achterrath W; Lenaz L
    Semin Oncol; 1990 Feb; 17(1 Suppl 2):25-31. PubMed ID: 2154856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the toxicity and efficacy of cisplatin and carboplatin in advanced ovarian cancer. The Swons Gynaecological Cancer Group.
    Adams M; Kerby IJ; Rocker I; Evans A; Johansen K; Franks CR
    Acta Oncol; 1989; 28(1):57-60. PubMed ID: 2650722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Results of a phase-I clinical study of carboplatin--(cyclobutane-1,1-dicarboxylate)diamineplatinum (II)].
    Gorbunova VA
    Vestn Akad Med Nauk SSSR; 1986; (5):45-7. PubMed ID: 3524054
    [No Abstract]   [Full Text] [Related]  

  • 20. A pilot study of CHAC-1.
    ten Bokkel Huinink WW; vd Burg ME; von Oosterom AT; Vermorken JB; Veenhof C; Roosendaal K
    Cancer Treat Rev; 1985 Sep; 12 Suppl A():77-82. PubMed ID: 3936615
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.